Essex Investment Management’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-250,109
Closed -$2.36M 329
2024
Q1
$2.36M Buy
250,109
+3,776
+2% +$32.4K 0.47% 83
2023
Q4
$1.93M Sell
246,333
-17,399
-7% -$126K 0.38% 103
2023
Q3
$1.77M Sell
263,732
-5,338
-2% -$43.7K 0.29% 118
2023
Q2
$2.63M Buy
269,070
+31,982
+13% +$325K 0.37% 97
2023
Q1
$2.29M Buy
237,088
+34,118
+17% +$297K 0.33% 99
2022
Q4
$1.53M Buy
+202,970
New +$1.37M 0.24% 127

Other funds holding VMD

Essex Investment Management's VMD Position: Q2 2024 in Review

Essex Investment Management sold out of Viemed Healthcare (VMD) in Q2 2024, closing a stake of 250,109 shares — an estimated $2.36M sold.

Essex Investment Management first reported a position in VMD in Q4 2022 and held it in 6 quarters. The position peaked at $2.63M in Q2 2023. 116 funds tracked by Wall St. Rank hold VMD as of Q2 2024.

  • Essex Investment Management reported no remaining Viemed Healthcare position as of Q2 2024 after selling out during the quarter.
  • Essex Investment Management sold 250,109 Viemed Healthcare shares in Q2 2024, an estimated $2.36M.
  • Essex Investment Management first reported a position in Viemed Healthcare in Q4 2022 and held it in 6 quarters.
  • Essex Investment Management's Viemed Healthcare position peaked at $2.63M in Q2 2023.
  • 116 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2024.

Based on Essex Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.